Citation Impact
Citing Papers
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
2008
Intracellular Nucleic Acid Sensors and Autoimmunity
2011 StandoutNobel
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease
2015
The Presence of Anti-Neutrophil Antibodies Reflects Clinical and Genetic Heterogeneity Within Inflammatory Bowel Disease
1998
Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial
2003
The Tuberous Sclerosis Complex
2006 Standout
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
2004 Standout
Review article: the role of butyrate on colonic function
2007 Standout
Antineutrophil cytoplasmic antibodies
2006
High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity
2007
High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine
2003
Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis
2002
Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors
2006
Renal angiomyolipomata
2004
A DNA microarray study of nitric oxide-induced genes in mouse hepatocytes: implications for hepatic heme oxygenase-1 expression in ischemia/reperfusion
2002
Antithyroid Drugs
2005
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
2016 Standout
A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
2000 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Ageing and infection
2002 Standout
Tuberous sclerosis
2008 Standout
Antithyroid Drug-Induced Hematopoietic Damage: A Retrospective Cohort Study of Agranulocytosis and Pancytopenia Involving 50,385 Patients with Graves' Disease
2011
Lack of Current Clinical Value of Serological Testing in the Evaluation of Patients with IBD
1999
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Antineutrophil cytoplasmic antibodies
1998
Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus erythematosus
2005
Ulcerative colitis
2020 Standout
Differential Significance of Plasma Visfatin Concentrations according to Adiposity in Children and Adolescents
2013 Standout
The inflammatory response in myocardial injury, repair, and remodelling
2014 Standout
Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates
2009
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
Neutrophil recruitment and function in health and inflammation
2013 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus
2011
Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities
2007 Standout
Immunosenescence of microglia and macrophages: impact on the ageing central nervous system
2016
Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies
2006 Standout
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Antineutrophil Cytoplasmic Antibody–Positive Small-Vessel Vasculitis Associated with Antithyroid Drug Therapy: How Significant Is the Clinical Problem?
2015
Characteristics of Agranulocytosis as an Adverse Effect of Antithyroid Drugs in the Second or Later Course of Treatment
2013
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Tissue-Specific Inducible Expression of Antimicrobial Peptide Genes in Drosophila Surface Epithelia
2000 StandoutNobel
Colonic Bacteria Express an Ulcerative Colitis pANCA-Related Protein Epitope
2000
Nitric oxide and the immune response
2001 Standout
Ageing Is Associated with a Prolonged Fever Response in Human Endotoxemia
2001
Occurrence of Amphoterin (HMG1) as an Endogenous Protein of Human Platelets that Is Exported to the Cell Surface upon Platelet Activation
2000
High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
2008
Activation of gene expression in human neutrophils by high mobility group box 1 protein
2003
Addendum to the International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies: Quality Control Guidelines, Comments, and Recommendations for Testing in Other Autoimmune Diseases
2003
Minocycline: far beyond an antibiotic
2013 Standout
Inhibition of Activation of the Classical Pathway of Complement by Human Neutrophil Defensins
1998
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
At the Crossroads of Necrosis and Apoptosis: Signaling to Multiple Cellular Targets by HMGB1
2002
High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis
2003
Inhibition of Activation of the Classical Pathway of Complement by Human Neutrophil Defensins
1998
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Concomitant Agranulocytosis and Hepatotoxicity After Treatment with Carbimazole
2006
DAMPs, PAMPs and alarmins: all we need to know about danger
2006 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Addendum to the International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies
2003
Factors masking HMGB1 in human serum and plasma
2006
Works of J Sobajima being referenced
High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis
1999
Multifocal Micronodular Pneumocyte Hyperplasia and Lymphangioleiomyomatosis in Tuberous Sclerosis with a TSC2 Gene
2001
Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases.
1998
Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC)
1998
Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type
1996
Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity
2002
Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2
1997